Cheng Sohanya Roshan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Cheng Sohanya Roshan（CIK 1865796）在 1 家公司共报告 7 笔 SEC Form 4 内部人交易（最近一笔 2026-05-15）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 买入 | 947 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 卖出 | 324 | $3,078 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 卖出 | 4,604 | $43,324 |
| 2026-02-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 买入 | 32,415 | $0 |
| 2025-10-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 买入 | 43,650 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 买入 | 945 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 卖出 | 325 | $2,090 |
来源：SEC Form 4 申报文件 · 截至 2026-05-15